Heinrich Schell
Impact in
- Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological diseases and metabolism
-
- Nuclear Receptors and Signaling
- Nerve injury and regeneration
- Genetic Neurodegenerative Diseases
Papers in
-
- Parkinson's Disease Mechanisms and Treatments 9
- Neurological disorders and treatments 3
- Neuroinflammation and Neurodegeneration Mechanisms 1
-
- Nerve injury and regeneration 5
- Nuclear Receptors and Signaling 4
- Neuroscience and Neuropharmacology Research 1
- Co-authors
- Philipp J. Kahle (9 shared papers)Manuela Neumann (1 shared paper)Takafumi Hasegawa (1 shared paper)Abid Oueslati (1 shared paper)Ahmed Boucharaba (1 shared paper)Markus Zweckstetter (1 shared paper)Margot Fournier (1 shared paper)Guowei Yin (1 shared paper)
- Journals
- Journal of Neurochemistry (2 papers)PLoS ONE (2 papers)The FASEB Journal (1 paper)Amyloid (1 paper)Neuroscience (1 paper)
- Partner nations
- GermanySwedenSwitzerland
In The Last Decade
Heinrich Schell
9 papers receiving 794 citations
Peers
Comparison fields: 5 of 56
- Neurology 618
- Cellular and Molecular Neuroscience 368
- Neurology 165
- Physiology 267
- Cell Biology 72
Countries citing papers authored by Heinrich Schell
This map shows the geographic impact of Heinrich Schell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heinrich Schell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heinrich Schell more than expected).
Fields of papers citing papers by Heinrich Schell
This network shows the impact of papers produced by Heinrich Schell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heinrich Schell. The network helps show where Heinrich Schell may publish in the future.
Co-authors
The 25 scholars most cited alongside Heinrich Schell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 205 | |
| 2 | 2009 | 145 | |
| 3 | 2014 | 106 | |
| 4 | 2009 | 102 | |
| 5 | 2011 | 87 | |
| 6 | 2013 | 74 | |
| 7 | 2014 | 48 | |
| 8 | 2013 | 23 | |
| 9 | 2012 | 15 |
About Heinrich Schell
Heinrich Schell is a scholar working on Neurology, Cellular and Molecular Neuroscience, Physiology, Complementary and alternative medicine and Neurology, having authored 9 papers that have together received 805 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (9 papers), Nerve injury and regeneration (5 papers), Nuclear Receptors and Signaling (4 papers), Neurological disorders and treatments (3 papers), Alzheimer's disease research and treatments (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (1 paper), Ginkgo biloba and Cashew Applications (1 paper) and Neuroscience and Neuropharmacology Research (1 paper). The work is most often cited by research in Neurology (618 citations), Cellular and Molecular Neuroscience (368 citations), Neurology (165 citations), Physiology (267 citations) and Cell Biology (72 citations). Heinrich Schell has collaborated with scholars based in Germany, Sweden and Switzerland. Frequent co-authors include Philipp J. Kahle, Manuela Neumann, Takafumi Hasegawa, Abid Oueslati, Ahmed Boucharaba, Markus Zweckstetter, Margot Fournier, Guowei Yin, Eliezer Masliah and Martial Mbefo. Their work appears in journals such as Journal of Neurochemistry, PLoS ONE, The FASEB Journal, Amyloid and Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.